Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 621, pseudogene (RN7SL621P) is a human pseudogene corresponding to a nonfunctional copy of the 7SL RNA gene, which encodes the RNA backbone of the signal recognition particle (SRP) complex. The 7SL RNA is a conserved non-coding RNA critical for directing newly synthesized proteins to the endoplasmic reticulum in eukaryotic cells. As a pseudogene, RN7SL621P is generally not transcribed into a functional RNA, nor is it known to encode any protein or play a direct biological role. No evidence supports its function as a therapeutic target, nor its clinical role as a biomarker or drug-interacting molecule. However, pseudogenes can sometimes regulate gene expression at the RNA level in a sequence-dependent manner, but there is no specific evidence for this for RN7SL621P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 621, pseudogene (RN7SL621P).